Daniel Breen
Research Associate II, Translational Research
Daniel graduated from University College Dublin with a BSc. in Biomedical, Health and Life Sciences. During his studies, he gained an appreciation for human health and disease, in addition to the diagnostics and therapeutics which aim to address unmet clinical needs. As part of his final stage thesis, he worked within the translational oncology group of Professor Amanda McCann, PhD in the UCD Conway Institute of Biomolecular and Biomedical Research. During his time there, he assessed the impact of CXCL8 on cutaneous malignant melanoma progression in vitro in further elucidating the proteomic signatures of patients with cutaneous malignant melanoma.
